Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: PD-0332991 and T-DM1
Sponsor: University of Texas Southwestern Medical Center
Collaborators: Pfizer|University of Pennsylvania